Literature DB >> 6328330

Effects of ceruletide and cholecystokinin octapeptide on eating in mice. Interactions with naloxone and the enkephalin analogue, FK 33-824.

G Zetler, K H Mörsdorf.   

Abstract

Subcutaneous (SC) injections of ceruletide (caerulein diethylammonium hydrate, CER) and the octapeptide of cholecystokinin (CCK-8) reduced the intake of liquid food in male NMRI mice starved for 18 h. The corresponding ED50 values were 2 micrograms/kg for CER and 24 micrograms/kg for CCK-8; hence, on a molar basis, CER was 14 times more potent than CCK-8. Naloxone (0.2 and 1 mg/kg, SC) inhibited eating. (D-Ala)2(MePhe)4-(Met(O)-ol)5-enkephalin (FK 33-824; 0.3 and 1 mg/kg) was only stimulatory. Naloxone enhanced the effect of CER, whereas FK 33-824 antagonized it. It is concluded that concerning the inhibition of food intake, opioid peptides can be antagonists of CCK-like peptides. This is consistent with the current view of the regulation of appetitive behaviour.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328330     DOI: 10.1007/bf00495945

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

2.  Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide.

Authors:  C L McLaughlin; C A Baile
Journal:  Physiol Behav       Date:  1981-03

Review 3.  Minireview. The ascent of cholecystokinin (CCK) - from gut to brain.

Authors:  J E Morley
Journal:  Life Sci       Date:  1982-02-07       Impact factor: 5.037

4.  Cholecystokinin inhibits food intake in genetically obese (C57BL/6j-ob) mice.

Authors:  A J Strohmayer; G P Smith
Journal:  Peptides       Date:  1981       Impact factor: 3.750

5.  Effects of beta-endorphin, thyrotropin-releasing hormone and cholecystokinin on body shaking behavior in rats.

Authors:  S Itoh; G Katsuura
Journal:  Jpn J Physiol       Date:  1982

6.  Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.

Authors:  G Zetler
Journal:  Neuropharmacology       Date:  1982-08       Impact factor: 5.250

7.  The role of central and peripheral cholecystokinin in mediating appetitive behaviors.

Authors:  J N Crawley; J A Rojas-Ramirez; W B Mendelson
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

8.  Interactions of caerulein and morphine on gastrointestinal propulsion in the mouse.

Authors:  E Scheufler; G Zetler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

9.  beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

Authors:  D L Margules; B Moisset; M J Lewis; H Shibuya; C B Pert
Journal:  Science       Date:  1978-12-01       Impact factor: 47.728

10.  Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.

Authors:  M Deschodt-Lanckman; N D Bui; M Noyer; J Christophe
Journal:  Regul Pept       Date:  1981-04
View more
  1 in total

1.  Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.

Authors:  T Griesbacher; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.